Human Antibody Responses to the Polyclonal Dryvax Vaccine for Smallpox Prevention Can Be Distinguished from Responses to the Monoclonal Replacement Vaccine ACAM2000

Unusual Features of Vaccinia Virus Extracellular Virion Form Neutralization Resistance Revealed in Human Antibody Responses to the Smallpox Vaccine

(2012) Mohammed Rafii-El-Idrissi Benhnia et al.   JOURNAL OF VIROLOGY

Humoral Immunity to Smallpox Vaccines and Monkeypox Virus Challenge: Proteomic Assessment and Clinical Correlations

(2012) M. B. Townsend et al.   JOURNAL OF VIROLOGY

Elucidating the Role of the Complement Control Protein in Monkeypox Pathogenicity

(2012) Paul N. Hudson et al.   PLoS One

The Vaccinia Virus O1 Protein Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase 1/2 and Promotes Viral Virulence

(2011) M. Schweneker et al.   JOURNAL OF VIROLOGY

Genomic Analysis of the Vaccinia Virus Strain Variants Found in Dryvax Vaccine

(2011) L. Qin et al.   JOURNAL OF VIROLOGY

An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies

(2011) Chungui Xu et al.   VIROLOGY

Smallpox vaccines: targets of protective immunity

(2010) Bernard Moss   IMMUNOLOGICAL REVIEWS

The Vaccinia Virus Complement Control Protein Modulates Adaptive Immune Responses during Infection

(2010) N. M. Girgis et al.   JOURNAL OF VIROLOGY

Poxvirus Complement Control Proteins Are Expressed on the Cell Surface through an Intermolecular Disulfide Bridge with the Viral A56 Protein

(2010) B. C. DeHaven et al.   JOURNAL OF VIROLOGY

Proteomic Basis of the Antibody Response to Monkeypox Virus Infection Examined in Cynomolgus Macaques and a Comparison to Human Smallpox Vaccination

(2010) Sarah Keasey et al.   PLoS One

Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection

(2010) Rajeev Rudraraju et al.   VACCINE

The immunology of smallpox vaccines

(2009) Richard B Kennedy et al.   CURRENT OPINION IN IMMUNOLOGY

Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5

(2009) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Predicted poxvirus FEN1-like nuclease required for homologous recombination, double-strand break repair and full-size genome formation

(2009) T. G. Senkevich et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax

(2008) C. M. Midgley et al.   JOURNAL OF GENERAL VIROLOGY

Comparative Proteomics of Human Monkeypox and Vaccinia Intracellular Mature and Extracellular Enveloped Virions

(2008) Nathan P. Manes et al.   JOURNAL OF PROTEOME RESEARCH

Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine

(2008) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Analysis of the human immune response to vaccinia by use of a novel protein microarray suggests that antibodies recognize less than 10% of the total viral proteome

(2008) Kara Schmid et al.   Proteomics Clinical Applications

Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults

(2008) Sharon E. Frey et al.   VACCINE

Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment

(2007) Erika Hammarlund et al.   VACCINE